Skip to content
Disclosery

EXANE DERIVATIVES: DHI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on DHI, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 8,336 DHI shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 8,336 shares
    Change vs previous 13F -3,309 shares

    0.32% of the 13F portfolio, value $551,693.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 11,645 shares
    Change vs previous 13F +1,762 shares

    0.24% of the 13F portfolio, value $867,675.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 9,883 shares
    Change vs previous 13F +9,522 shares

    0.26% of the 13F portfolio, value $1,071,846.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 361 shares
    Change vs previous 13F -4,400 shares

    0.01% of the 13F portfolio, value $30,314.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4,761 shares
    Change vs previous 13F +3,714 shares

    0.1% of the 13F portfolio, value $411,882.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,047 shares
    Change vs previous 13F -6,366 shares

    0.03% of the 13F portfolio, value $93,312.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 7,413 shares
    Change vs previous 13F +7,387 shares

    0.15% of the 13F portfolio, value $510,922.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 26 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $1,966.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).